Baker Avenue Asset Management’s Exact Sciences EXAS Stock Holding History

Baker Avenue Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-16	Closed	-$1.09K	–	719
2023 Q3	$1.09K	Hold	16	–	–	﹤0.01%	1253
2023 Q2	$1.5K	Hold	16	–	–	﹤0.01%	1052
2023 Q1	$1.08K	Hold	16	–	–	﹤0.01%	1155
2022 Q4	$792	Buy	+16	New	+$654	﹤0.01%	1180
2020 Q1	–	Sell	-17,818	Closed	-$1.65M	–	208
2019 Q4	$1.65M	Buy	17,818 +13,818	+345%	+$1.21M	0.12%	118
2019 Q3	$361K	Buy	+4,000	New	+$456K	0.03%	195
2017 Q2	–	Sell	-35,251	Closed	-$833K	–	206
2017 Q1	$833K	Buy	35,251 +795	+2%	+$15.8K	0.11%	111
2016 Q4	$460K	Buy	34,456 +4,325	+14%	+$69.8K	0.06%	157
2016 Q3	$560K	Buy	+30,131	New	+$531K	0.08%	129

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Baker Avenue Asset Management's EXAS Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 16 shares — an estimated $1.09K sold.

Baker Avenue Asset Management first reported a position in EXAS in Q3 2016 and held it in 9 quarters. The position peaked at $1.65M in Q4 2019. 647 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

Baker Avenue Asset Management reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
Baker Avenue Asset Management sold 16 Exact Sciences shares in Q4 2023, an estimated $1.09K.
Baker Avenue Asset Management first reported a position in Exact Sciences in Q3 2016 and held it in 9 quarters.
Baker Avenue Asset Management's Exact Sciences position peaked at $1.65M in Q4 2019.
647 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.